Artera has raised a total of $110 million across multiple funding rounds, including a $20 million round in February 2024, backed by Prosperity7 Ventures. The Los Altos-based healthcare AI company develops multimodal AI-based predictive and prognostic cancer tests to personalize treatments for cancer patients. With a workforce of 101–250 employees, Artera combines digital pathology and clinical data to deliver individualized treatment recommendations, primarily for prostate cancer.
Keep reading to explore Artera’s funding journey, key investors, and what’s next for this innovative healthcare AI company.
What Is Artera and What Does It Do?
Founded in 2021 by Andre Esteva and Felix Feng, Artera is headquartered in Los Altos, California, United States. The company specializes in multimodal AI-based predictive and prognostic cancer tests that customize therapy for patients.
Artera’s platform integrates digital pathology images and clinical data to predict treatment response and disease progression, enabling oncologists to make precise therapeutic decisions. Its flagship prostate cancer test is the first AI-based test to receive Medicare payment rates in the U.S.
How Much Funding Has Artera Raised?
- Series A
- Amount Raised: $90M
- Date: March 2023
- Motivation: To emerge from stealth mode, accelerate AI research, and support the commercialization of its prostate cancer test.
- Series B
- Amount Raised: $20M
- Date: February 2024
- Lead Investors: Prosperity7 Ventures, EDBI, Walden Catalyst Ventures, Wilson Sonsini Goodrich & Rosati, Trium Ventures, Navin Chaddha, Rajiv Khemani, Andrew & Elliott Tan
- Motivation: To support international expansion and commercial growth, furthering Artera’s mission to personalize cancer therapy through AI-enabled predictive and prognostic tests.
Total Funding Raised: $110M
Latest Funding Date: February 2024
Key Investors
- Prosperity7 Ventures
- Details: Diversified growth fund of Aramco Ventures, focusing on transformative technologies and next-generation business models.
- Investment Focus Areas: Breakthrough technologies, healthcare AI, deep tech innovation
- Notable Investments: Artera, emerging healthcare AI startups
- EDBI
- Details: Singapore-based global investor supporting high-growth companies expanding into Asia.
- Investment Focus Areas: Healthcare, AI, emerging technology
- Notable Investments: Artera, precision medicine ventures
- Walden Catalyst Ventures
- Details: Venture capital firm investing in frontier technologies and AI-driven innovation.
- Investment Focus Areas: AI, computational biology, healthcare technology
- Notable Investments: Artera, early-stage deep tech companies
- Wilson Sonsini Goodrich & Rosati
- Details: Leading law firm supporting startups through strategic investment and advisory.
- Investment Focus Areas: Legal-tech partnerships, biotech, healthcare innovation
- Notable Investments: Artera, emerging biotech ventures
- Trium Ventures
- Details: Venture capital firm investing in technology and healthcare startups.
- Investment Focus Areas: AI in healthcare, predictive medicine, life sciences
- Notable Investments: Artera, precision medicine technologies
- Andrew & Elliott Tan, Navin Chaddha, Rajiv Khemani
- Details: Angel investors backing Artera’s AI-driven approach to cancer treatment.
- Investment Focus Areas: Healthcare AI, predictive analytics, oncology innovation
- Notable Investments: Artera, healthcare AI startups
Where Is Artera’s Headquarters?
Artera is headquartered in Los Altos, California, United States, providing access to leading research institutions, medical centers, and venture partners in the healthcare and AI sectors.
What’s Next for Artera?
Following its $20 million funding round in February 2024, Artera is poised for international expansion, broadening global reach and deepening partnerships with oncology institutions. The company continues to enhance its AI algorithms, pursue regulatory approvals, and scale its precision oncology solutions.
Future fundraising is expected as Artera expands beyond prostate cancer into new cancer types. With growing adoption of AI in medicine, Artera is positioned as a leader in personalized cancer care.
Get Investor & Funding Insights with TexAu
TexAu provides detailed fundraising data on companies like Artera. Track investors, monitor funding rounds, and gather actionable insights to strengthen your sales and business strategy.
Sign up for Free on TexAu and turn data into smarter, faster business decisions.
